Can deuterated colexitinib (decavatinib) relieve joint pain caused by psoriasis?

Deucravacitinib is an oral, selective tyrosine kinase 2 (TYK2) inhibitor that is mainly used for the treatment of moderate to severe plaque psoriasis. Patients with psoriasis are often accompanied by symptoms of arthritis, including joint pain, swelling, and morning stiffness, which seriously affect their quality of life. Decavatinib reduces the production of inflammatory mediators by inhibiting the IL-12, IL-23, and Type I interferon signaling pathways, thereby potentially alleviating inflammation of the skin and joints.

Clinical studies have shown that decavatinib can not only significantly improve psoriasis skin lesions, but also alleviate psoriasis-related joint symptoms to a certain extent. Some patients reported reduced joint pain, improved joint range of motion, and shorter morning stiffness after weeks to months of treatment with decavatinib. Especially for patients with mild to moderate psoriatic arthritis (PsA), the anti-inflammatory effects of TYK2 inhibitors can help control local inflammation in joints and reduce pain and swelling.

It should be noted that although decavatinib has shown certain effects in improving joint symptoms, its main approved indication is still plaque psoriasis, and the efficacy data on psoriatic arthritis is relatively limited. Therefore, if the joint pain is obvious or the condition is complex, it still needs to be comprehensively evaluated under the guidance of a rheumatologist or dermatologist, and if necessary, combined with non-steroidal anti-inflammatory drugs (NSAIDs), DMARDs or biological agents for combined treatment to obtain more comprehensive relief of joint symptoms.

Overall, deuterated colexitinib has a potential role in relieving joint pain caused by psoriasis, but there are individual differences in efficacy. Patients should be followed up regularly during use to evaluate skin and joint reactions and adjust treatment plans in a timely manner. At the same time, combined with moderate exercise and physical therapy, it can help maintain joint function and reduce pain, ensuring better comprehensive management of psoriasis and joint symptoms.

Reference materials:https://www.drugs.com/